Lyell Immunopharma, Inc. (LYEL)

NMS – Real Time Price. Currency in USD

14.34

-0.55 (-3.66%)

Market open: Aug 12, 2026, 1:02 PM EDT

14.61

-0.27 (-1.81%)

Previous after-hours: Aug 11, 2026, 6:11 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

36K

61K

130K

85M

Cost of goods sold

-12M

-20M

-16M

Gross Profit

-12M

-20M

68M

Operating expenses (excl. COGS)

-192M

-204M

-231M

-260M

Operating Income

-204M

-224M

-251M

-192M

Non-operating income, total

-71M

-119M

16M

Pretax income

-274M

-343M

-235M

-183M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-274M

-343M

-235M

-183M

Discontinued operations

Net income

-274M

-343M

-235M

-183M

Dilution adjustment

Preferred dividends

Lyell Immunopharma, Inc. (LYEL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Lyell Immunopharma, Inc. (LYEL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Lyell Immunopharma, Inc. (LYEL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Lyell Immunopharma, Inc. (LYEL)

Income Statement (Annual)

Income Statement (Annual)